Results 91 to 100 of about 291,679 (168)
Gestante añosa como factor de riesgo para macrosomía fetal en pacientes del Hospital Belén de Trujillo [PDF]
Objetivo: Determinar si el ser gestante añosa es factor de riesgo para macrosomía fetal en pacientes del Hospital Belen de Trujillo. Material y Métodos: Se llevó a cabo un estudio de tipo analítico, observacional, retrospectivo, de cohortes ...
Chero Narvaez, Rodrigo Paúl
core
Factores de riesgo asociados a Macrosomía Fetal en mujeres con Embarazo de Término atendidas en el Hospital España, Chinandega 2019 [PDF]
El objetivo del presente trabajo fue determinar los Factores de Riesgo Asociados a Macrosomía Fetal en Mujeres con Embarazo de Término Atendidas en el Hospital España, Chinandega 2019.
Pérez Vallejos, Kevin Javier +1 more
core
Physical activity during pregnancy in women with type 1 or type 2 diabetes: A scoping review
Abstract Aim Physical activity (PA) is recommended during pregnancy for its health benefits. While general PA guidance exists for uncomplicated pregnancies, evidence specific to women with pre‐existing type 1 diabetes or type 2 diabetes (T1D; T2D) is limited.
Holly Mei Jones +6 more
wiley +1 more source
Abstract Aims To investigate the clinical use, in early pregnancy in women living with type 1 diabetes (T1D), of automated insulin delivery (AID) systems lacking pregnancy‐specific algorithms and to evaluate the maternal and glycaemic outcomes associated with their implementation in routine care. Methods This observational study included women with T1D
Sara Hallström +2 more
wiley +1 more source
Objetivos: Determinar los factores de riesgo maternos relacionados a la presentación de macrosomía fetal en el hospital naval durante julio 2014 - julio 2016. Métodos: Investigación observacional, analítico, caso-control.
Raúl Arturo Córdova-Verástegui +2 more
doaj +1 more source
ABSTRACT Background Gestational diabetes mellitus (GDM) complicates roughly one in seven pregnancies and predicts later maternal type 2 diabetes mellitus (T2DM). Yet its pharmacological management still rests on a handful of agents (insulin, metformin and glibenclamide), none of them selected on the basis of the disease's molecular genetics.
Wael Osman
wiley +1 more source
Glycaemic Management and Pregnancy Outcomes in HNF1A‐MODY
ABSTRACT Introduction Birthweight of HNF1A‐affected offspring is largely similar to the background population with rarely reported cases of large for gestational age (LGA) and neonatal hypoglycaemia (NH). Conventional clinical management of pre‐gestational diabetes appears to be sufficient in managing HNF1A‐affected women in pregnancy.
M. T. Crowley +10 more
wiley +1 more source
Assessing the risk factors and establishing multivariable prediction models for singleton macrosomia
IntroductionFetal macrosomia is related to adverse neonatal and maternal health outcomes. Therefore, we aimed to evaluate the risk factors for macrosomia and establish multivariable prediction models to enable early identification, prevention, and ...
Jinying Luo +14 more
doaj +1 more source
Relación de la macrosomía fetal y las complicaciones maternas y neonatales en el hospital de San Juan de Lurigancho del año - 2018 [PDF]
El presente estudio fue planteado con el objetivo de Determinar la relación de la macrosomía fetal y las complicaciones maternas y neonatales en el hospital de san juan de Lurigancho del año 2018.Material y métodos.
Luna Quiñones, Joselyn Renee
core
ABSTRACT Background and Aims Metformin is increasingly used to treat gestational diabetes mellitus and other insulin‐resistant conditions during pregnancy. Because it crosses the placenta, concerns remain regarding its potential effects on offspring growth and metabolic programming.
Otilia Perichart‐Perera +2 more
wiley +1 more source

